MERCK Kommanditgesellschaft auf Aktien, a science and technology company in Germany. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, cardiovascular and metabolic diseases. The company supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as provides solutions for automotive coatings, cosmetics, and industrial applications. The company serves life science, healthcare, and electronics sectors. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm and Lausanne. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.